| Family Care Medical Center | |
|
819 N Mills Ave Arcadia FL 34266-8716 | |
| (863) 491-2277 | |
| (863) 491-3077 |
| Full Name | Family Care Medical Center |
|---|---|
| Speciality | Family Medicine |
| Location | 819 N Mills Ave, Arcadia, Florida |
| Authorized Official Name and Position | Kenan M Cetin (OWNER) |
| Authorized Official Contact | 8634912277 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Care Medical Center 819 N Mills Ave Arcadia FL 34266-8716 Ph: (863) 491-2277 | Family Care Medical Center 819 N Mills Ave Arcadia FL 34266-8716 Ph: (863) 491-2277 |
| NPI Number | 1114514809 |
|---|---|
| Provider Enumeration Date | 12/29/2020 |
| Last Update Date | 07/21/2021 |
| Medicare PECOS PAC ID | 4587077409 |
|---|---|
| Medicare Enrollment ID | O20210113001197 |
News Archive
G protein-coupled receptors are the largest class of cell surface receptors in our cells, involved in signal transmission across the cell membrane.
Stem cells, delivered intranasally, were found to substantially improve motor function in Parkinson's disease in a study co-authored by William H. Frey II, Ph.D, Director of the Alzheimer's Research Center, part of HealthPartners Research Foundation. Frey collaborated with Lusine Danielyan, MD, of University Hospital of Tubingen in Germany.
To address the lack of ethnically diverse patients in clinical trials across the U.S., AstraZeneca has announced, in collaboration with the National Medical Association (NMA) and the Interamerican College of Physicians and Surgeons (ICPS), new efforts to increase ethnically diverse physician investigator participation in clinical trials.
People with type 1 diabetes are at high risk of developing kidney disease, but no therapies are proven to prevent impaired kidney function in these patients. In the Diabetes Control and Complications Trial (DCCT), Ian de Boer, MD and his team looked to see if intensive diabetes therapy aimed at reducing blood sugar as close to the normal range as possible might protect type 1 diabetics' kidney function. The study's results were presented during the American Society of Nephrology's Annual Kidney Week.
Hospira, a leading provider of clinical information and medication delivery technologies, today announced the launch of its enhanced TheraDoc™ clinical surveillance system, used by hospitals to help improve patient safety and prevent adverse events such as healthcare-associated infections (HAIs).
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114514809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 363AM0700X | Physician Assistant - Medical | (* (Not Available)) | Secondary |
| Provider Name | Wayne M Goldstein |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1154426146 PECOS PAC ID: 0446252977 Enrollment ID: I20070212000548 |
News Archive
G protein-coupled receptors are the largest class of cell surface receptors in our cells, involved in signal transmission across the cell membrane.
Stem cells, delivered intranasally, were found to substantially improve motor function in Parkinson's disease in a study co-authored by William H. Frey II, Ph.D, Director of the Alzheimer's Research Center, part of HealthPartners Research Foundation. Frey collaborated with Lusine Danielyan, MD, of University Hospital of Tubingen in Germany.
To address the lack of ethnically diverse patients in clinical trials across the U.S., AstraZeneca has announced, in collaboration with the National Medical Association (NMA) and the Interamerican College of Physicians and Surgeons (ICPS), new efforts to increase ethnically diverse physician investigator participation in clinical trials.
People with type 1 diabetes are at high risk of developing kidney disease, but no therapies are proven to prevent impaired kidney function in these patients. In the Diabetes Control and Complications Trial (DCCT), Ian de Boer, MD and his team looked to see if intensive diabetes therapy aimed at reducing blood sugar as close to the normal range as possible might protect type 1 diabetics' kidney function. The study's results were presented during the American Society of Nephrology's Annual Kidney Week.
Hospira, a leading provider of clinical information and medication delivery technologies, today announced the launch of its enhanced TheraDoc™ clinical surveillance system, used by hospitals to help improve patient safety and prevent adverse events such as healthcare-associated infections (HAIs).
› Verified 8 days ago
| Provider Name | Achilles Kalnoky |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245460690 PECOS PAC ID: 4981859402 Enrollment ID: I20130306000214 |
News Archive
G protein-coupled receptors are the largest class of cell surface receptors in our cells, involved in signal transmission across the cell membrane.
Stem cells, delivered intranasally, were found to substantially improve motor function in Parkinson's disease in a study co-authored by William H. Frey II, Ph.D, Director of the Alzheimer's Research Center, part of HealthPartners Research Foundation. Frey collaborated with Lusine Danielyan, MD, of University Hospital of Tubingen in Germany.
To address the lack of ethnically diverse patients in clinical trials across the U.S., AstraZeneca has announced, in collaboration with the National Medical Association (NMA) and the Interamerican College of Physicians and Surgeons (ICPS), new efforts to increase ethnically diverse physician investigator participation in clinical trials.
People with type 1 diabetes are at high risk of developing kidney disease, but no therapies are proven to prevent impaired kidney function in these patients. In the Diabetes Control and Complications Trial (DCCT), Ian de Boer, MD and his team looked to see if intensive diabetes therapy aimed at reducing blood sugar as close to the normal range as possible might protect type 1 diabetics' kidney function. The study's results were presented during the American Society of Nephrology's Annual Kidney Week.
Hospira, a leading provider of clinical information and medication delivery technologies, today announced the launch of its enhanced TheraDoc™ clinical surveillance system, used by hospitals to help improve patient safety and prevent adverse events such as healthcare-associated infections (HAIs).
› Verified 8 days ago
News Archive
G protein-coupled receptors are the largest class of cell surface receptors in our cells, involved in signal transmission across the cell membrane.
Stem cells, delivered intranasally, were found to substantially improve motor function in Parkinson's disease in a study co-authored by William H. Frey II, Ph.D, Director of the Alzheimer's Research Center, part of HealthPartners Research Foundation. Frey collaborated with Lusine Danielyan, MD, of University Hospital of Tubingen in Germany.
To address the lack of ethnically diverse patients in clinical trials across the U.S., AstraZeneca has announced, in collaboration with the National Medical Association (NMA) and the Interamerican College of Physicians and Surgeons (ICPS), new efforts to increase ethnically diverse physician investigator participation in clinical trials.
People with type 1 diabetes are at high risk of developing kidney disease, but no therapies are proven to prevent impaired kidney function in these patients. In the Diabetes Control and Complications Trial (DCCT), Ian de Boer, MD and his team looked to see if intensive diabetes therapy aimed at reducing blood sugar as close to the normal range as possible might protect type 1 diabetics' kidney function. The study's results were presented during the American Society of Nephrology's Annual Kidney Week.
Hospira, a leading provider of clinical information and medication delivery technologies, today announced the launch of its enhanced TheraDoc™ clinical surveillance system, used by hospitals to help improve patient safety and prevent adverse events such as healthcare-associated infections (HAIs).
› Verified 8 days ago
Arcadia Int Medicine P A Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 830 N Mills Ave, Arcadia, FL 34266 Phone: 863-494-6599 Fax: 863-494-5467 | |
Community Care Family Healthcare Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1148 E Gibson St, Build C, Arcadia, FL 34266 Phone: 863-494-6222 Fax: 863-494-3227 | |
Twin Rivers Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 888 N Robert Ave, Arcadia, FL 34266 Phone: 863-494-8401 Fax: 863-993-7622 | |
Catalyst Walk-in Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1707 East Oak Street, Arcadia, FL 34266 Phone: 863-448-9242 Fax: 863-491-0760 | |
Family Care Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 819 N Mills Ave, Arcadia, FL 34266 Phone: 863-491-2277 Fax: 863-491-3077 | |
Ama Arcadia Pharmacy Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 425 Nursing Home Dr, Arcadia, FL 34266 Phone: 863-993-2966 Fax: 863-494-5491 |